ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMGastos comerciales, generales y administrativos32.73 M30.68 M29.13 M29.22 M28.02 M117.05 MInvestigación y desarrollo——————Beneficio operativo10.9 M126.64 M32.75 M-171.07 M-1.65 B-1.66 BTotal de ingresos no operativos-67.99 M-49.99 M-30.62 M28.16 M-3.89 M-56.34 MGastos por intereses, netos de intereses capitalizados55.66 M50.88 M55.3 M54.85 M65.67 M226.7 MIngresos no operativos, una vez deducidos los gastos por intereses-123.65 M-100.87 M-85.92 M-26.69 M-69.56 M-283.04 MIngresos/gastos extraordinarios——————Beneficio antes de impuestos246.18 M352.76 M248.16 M58.82 M-1.31 B-653.42 MParticipación en los beneficios6.63 M-507 K-9.02 M201 K-304 K-9.63 MImpuestos——————Participación minoritaria46.15 M47.6 M44.81 M34.91 M85.52 M212.84 MOtros ingresos/gastos después de impuestos——————Beneficio neto antes de actividades interrumpidas-62.24 M-8.94 M-107 M-232.75 M-1.08 B-1.43 BOperaciones suspendidas——————Beneficio neto-62.24 M-8.94 M-107 M-232.75 M-1.08 B-1.43 BAjuste por dilución——————Dividendos de las acciones preferentes——————Beneficio neto diluido atribuible a los accionistas-64.92 M-11.6 M-109.61 M-234.94 M-1.08 B-1.44 BBeneficio básico por acción-0.38-0.07-0.64-1.38-6.35-8.44Beneficio por acción diluido-0.38-0.07-0.64-1.38-6.35-8.44Número medio de acciones ordinarias172.07 M170.52 M170.13 M170.18 M170.31 M681.14 MAcciones diluidas172.07 M170.52 M170.13 M170.18 M170.31 M681.14 MEBITDA-51.59 M81.04 M-17.6 M-230.74 M-1.61 B-1.77 BEBIT-56.55 M76 M-22.55 M-235.57 M-1.61 B-1.79 BCosto de los ingresos240.43 M226.4 M224.43 M239.23 M232.54 M922.61 MOtros costes de producción240.43 M226.4 M224.43 M239.23 M232.54 M922.61 MAmortización y depreciación (flujo de caja)4.95 M5.04 M4.95 M4.83 M4.81 M19.63 M
Alexandria Real Estate Equities Inc
Alexandria Real Estate Equities, Inc. is a real estate investment trust based in Pasadena, California that invests in office buildings and laboratories leased to tenants in the life science and technology industries. Properties are generally located near universities to attract tenants. The company owns several major technology/biotechnology office campuses including the 740,972 square foot Alexandria Center for Life Science in Manhattan, and the 2,365,487 square foot Alexandria Center at Kendall Square and the 1,181,635 square foot Technology Square in the Boston area.
The company is dependent on the life sciences industry and funding for research by the United States Government.
The company also has a venture capital arm, Alexandria Venture Investments, which invests in life sciences firms.
The company is named after Alexandria, Egypt because of that city's connection to science.